ITGAM Protein
Overview
Integrin alpha-M (ITGAM), also known as CD11b, is a transmembrane glycoprotein that functions as a pattern recognition receptor and mediates cell-cell and cell-matrix interactions. The ITGAM gene is located on chromosome 16p11.2 and encodes a 1,096 amino acid protein belonging to the integrin family of adhesion molecules. ITGAM is primarily expressed on the surface of myeloid cells, including microglia, monocytes, macrophages, neutrophils, and dendritic cells. In the central nervous system (CNS), ITGAM is a key marker of microglial activation and plays a critical role in innate immune responses and neuroinflammation. The protein functions as the alpha subunit of the αMβ2 integrin (complement receptor 3), forming a heterodimer with integrin beta-2 (ITGB2). This complex serves as a crucial receptor for complement fragment iC3b and various ligands involved in immune recognition and phagocytosis.
Function and Biology
ITGAM mediates multiple essential immune functions through its capacity to bind diverse ligands and facilitate cell adhesion. The protein contains an I-domain (inserted domain) characteristic of integrin alpha chains, which is the primary ligand-binding region. This domain recognizes complement fragments, extracellular matrix proteins, and microbial pathogens. As part of the CR3 complex, ITGAM promotes recognition and phagocytosis of complement-opsonized particles, contributing to the clearance of pathogens and cellular debris.
...ITGAM Protein
Overview
Integrin alpha-M (ITGAM), also known as CD11b, is a transmembrane glycoprotein that functions as a pattern recognition receptor and mediates cell-cell and cell-matrix interactions. The ITGAM gene is located on chromosome 16p11.2 and encodes a 1,096 amino acid protein belonging to the integrin family of adhesion molecules. ITGAM is primarily expressed on the surface of myeloid cells, including microglia, monocytes, macrophages, neutrophils, and dendritic cells. In the central nervous system (CNS), ITGAM is a key marker of microglial activation and plays a critical role in innate immune responses and neuroinflammation. The protein functions as the alpha subunit of the αMβ2 integrin (complement receptor 3), forming a heterodimer with integrin beta-2 (ITGB2). This complex serves as a crucial receptor for complement fragment iC3b and various ligands involved in immune recognition and phagocytosis.
Function and Biology
ITGAM mediates multiple essential immune functions through its capacity to bind diverse ligands and facilitate cell adhesion. The protein contains an I-domain (inserted domain) characteristic of integrin alpha chains, which is the primary ligand-binding region. This domain recognizes complement fragments, extracellular matrix proteins, and microbial pathogens. As part of the CR3 complex, ITGAM promotes recognition and phagocytosis of complement-opsonized particles, contributing to the clearance of pathogens and cellular debris.
ITGAM undergoes conformational changes that regulate its adhesive function. The protein transitions between low-affinity and high-affinity ligand-binding states through "inside-out" signaling, where intracellular signals induce conformational rearrangement of the extracellular domain. This mechanism allows precise temporal and spatial control of immune cell activation and recruitment. In microglia, ITGAM expression and activation are tightly regulated by inflammatory mediators, including tumor necrosis factor-alpha (TNF-α) and interleukin-1 beta (IL-1β), which upregulate the receptor through NF-κB signaling pathways.
Role in Neurodegeneration
ITGAM has emerged as a significant genetic risk factor for Alzheimer's disease (AD) and other neurodegenerative conditions. Genome-wide association studies identified ITGAM variants as associated with increased AD susceptibility, highlighting the importance of microglial function in disease pathogenesis. The protein's role in neurodegeneration centers on microglial-mediated neuroinflammation, amyloid-beta clearance, and regulation of neuronal death pathways.
In Alzheimer's disease, ITGAM-positive microglia accumulate around amyloid plaques and tau tangles. However, the relationship is complex: while ITGAM mediates phagocytosis of amyloid-beta and debris, dysregulated ITGAM signaling can perpetuate chronic neuroinflammation through sustained production of pro-inflammatory cytokines and reactive oxygen species. ITGAM activation in the context of AD pathology may contribute to both neuroprotective amyloid clearance and neurotoxic inflammatory cascades, depending on microglial activation state and the presence of additional damage-associated molecular patterns (DAMPs).
Molecular Mechanisms
ITGAM mediates neurodegeneration through multiple interconnected mechanisms. First, ITGAM signaling activates phosphoinositide 3-kinase (PI3K) and focal adhesion kinase (FAK) pathways, triggering downstream activation of protein kinase B (Akt) and extracellular signal-regulated kinase (ERK1/2). These cascades promote pro-inflammatory gene transcription through NF-κB and activator protein-1 (AP-1) pathways.
Second, ITGAM-mediated recognition of complement-opsonized neurons can trigger phagocytosis of viable cells through complement-dependent cellular phagocytosis (CDCP). During neurodegeneration, increased complement deposition on neuronal surfaces due to neuronal stress or dying neurons may render them susceptible to ITGAM-mediated microglial uptake. This process involves recruitment of Src-family kinases and formation of actin-rich phagocytic cups.
Third, ITGAM signaling generates reactive oxygen species through NADPH oxidase (NOX2) activation, contributing to oxidative stress and secondary neuronal damage.
Clinical and Research Significance
The ITGAM-AD association has important implications for understanding microglial biology in neurodegeneration. ITGAM has been identified as a therapeutic target through drug development aimed at modulating microglial activation and reducing neuroinflammation. Additionally, ITGAM genetic variants have been studied as biomarkers for identifying individuals at higher risk for cognitive decline and AD progression.
- ITGB2 (Integrin beta-2)
- Microglia
- Neuroinflammation
- Complement system
- Alzheimer's disease genetics
- Amyloid-beta clearance